CoChat

Black Americans have an increased rate of angiotensin converting enzyme inhibitor-associated angioedema*

Brown, Nancy J., Ray, Wayne A., Snowden, Mary, Griffin, Marie R. · 1996 · Clinical Pharmacology & Therapeutics

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Abstract

Objective To study the association of race and other patient characteristics associated with angiotensin converting enzyme (ACE) inhibitor-associated angioedema. Methods This was a retrospective cohort study of participants in the Tennessee Medicaid Program ( >or= 15 years of age) to whom ACE inhibitors had been prescribed from 1986 through 1992. Results We identified 82 patients with confirmed angioedema during 51,752 person-years of ACE inhibitor use, giving an overall rate of angioedema of 1.6 per 1000 person-years of ACE inhibitor use. After potential confounding factors were controlled for, the adjusted relative risk (RR) of angioedema among black American users of ACE inhibitors was 4.5 (95% confidence interval [CI] 2.9 to 6.8) compared with white subjects. In addition to race, other factors associated with a significantly increased relative risk in the entire population were the first 30 days of ACE inhibitor use (RR, 4.6; 95% CI, 2.5 to 8.5) compared to > 1 year of use, use of either lisinopril (RR, 2.2; 95% CI, 1.2 to 3.9) or enalapril (RR, 2.2; 95% CI, 1.4 to 3.5) compared to captopril, and previous hospitalization for any diagnosis within 30 days (RR, 2.0; 95% CI, 1.1 to 3.6). Neither ACE inhibitor dose nor concurrent diuretic use was associated with the risk of angioedema. Conclusions These data suggest that black Americans have a substantially increased risk of ACE inhibitor-associated angioedema compared with white subjects and that this increased risk cannot be…

Overview

Integrity signals

Registry

Crossref · 10.1016/s0009-9236(96)90161-7

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 16 references

Research works printed but not linked: 1

  1. Cameron H. A., 1989, J Hum Hypertens, 3, 177

Cited by

See all 314

Metadata

Authors
Brown, N. J., Ray, W. A., Snowden, M., & Griffin, M. R.
Affiliations
Vanderbilt University (US)
Corresponding author
Brown, Nancy J.
Venue
Clinical Pharmacology & Therapeutics
Publisher
Wiley
Published
1996-07
Volume
60
Issue
1
Pages
8-13
ISSN
  • 0009-9236 (ISSN-L)
  • 1532-6535
OpenAlex
W2111856132
Cited by
313
References
15
Citations by year
2026: 3 · 2025: 8 · 2024: 10 · 2023: 11 · 2022: 7 · 2021: 10 · 2020: 10 · 2019: 12 · 2018: 18 · 2017: 18 · 2016: 19 · 2015: 7 · 2014: 9 · 2013: 17 · 2012: 15
FWCI
5.87
Type
journal article
Language
en
Open access
closed
Locations
  • Clinical Pharmacology & Therapeutics (publishedVersion)
  • PubMed (publishedVersion)
Funders
U.S. Food and Drug Administration (FD-U-000073)
Topics
  • Health Sciences › Medicine › Hematology › Coagulation, Bradykinin, Polyphosphates, and Angioedema
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
Keywords
ACE inhibitors, race, African Americans, racial disparities, lisinopril, enalapril, captopril, recent hospitalization, drug safety
MeSH terms
Adolescent, Adult, Aged, Angioedema, Angiotensin-Converting Enzyme Inhibitors, Black or African American, Female, Humans, Male, Middle Aged, Retrospective Studies, Risk Factors, Cohort Studies, Multivariate Analysis, Black People

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Black Americans have an increased rate of angiotensin converting enzyme inhibitor-associated angioedema*. https://app.cochat.ai/papers/10.1016/s0009-9236(96)90161-7
The paper
Brown, N. J., Ray, W. A., Snowden, M., & Griffin, M. R. (1996). Black Americans have an increased rate of angiotensin converting enzyme inhibitor-associated angioedema*. Clinical Pharmacology & Therapeutics. https://doi.org/10.1016/s0009-9236(96)90161-7

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.